Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1882 Target Snapshot

Neuronal acetylcholine receptor subunit alpha-4 · SINGLE PROTEIN · Homo sapiens

1,247Compounds
5Assays
0Approved Drugs
81.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P43681. Use UniProt P43681 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P43681 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Neuronal acetylcholine receptor subunit alpha-4 as ChEMBL target CHEMBL1882, mapped to UniProt P43681. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Neuronal acetylcholine receptor subunit alpha-4
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL1882
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P43681
Neuronal acetylcholine receptor subunit alpha-4
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Neuronal acetylcholine receptor subunit alpha-4 is the right protein anchor across sources, using UniProt P43681 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNeuronal acetylcholine receptor subunit alpha-4
UniProt AccessionP43681
Component TypeProtein
Sequence Length627 aa

Neuronal acetylcholine receptor subunit alpha-4

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Neuronal acetylcholine receptor subunit alpha-4, mapped to UniProt P43681. Sequence length is 627 aa.

Mapped IDP43681
Review nameNeuronal acetylcholine receptor subunit alpha-4
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

IC501.0
KI80.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2179534 8.82 Ki 1.5 Preclinical
CHEMBL3676980 8.8 Ki 1.6 Preclinical
CHEMBL2179547 8.77 Ki 1.7 Preclinical
CHEMBL2179531 8.62 Ki 2.4 Preclinical
CHEMBL2179540 8.34 Ki 4.6 Preclinical
CHEMBL3676962 8.31 Ki 4.9 Preclinical
CHEMBL2179544 8.28 Ki 5.2 Preclinical
CHEMBL3676982 8.28 Ki 5.2 Preclinical
CHEMBL2179543 8.14 Ki 7.3 Preclinical
CHEMBL3676986 8.06 Ki 8.7 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
0
5.5
1
6.0
5
6.5
31
7.0
30
7.5
10
8.0
4
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

5
Total Assays
80
Tested Compounds
2
Assay Types
Binding — 4 assays, 80 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 4 80 7.5
Functional — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 1 6.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine